Structure Info
- Chemspace ID
- CSSS00054050353 (In-Stock Screening Compounds)
- CAS
- 20064-19-1
- MFCD
- MFCD00870024, MFCD00209823
- IUPAC Name
- (3R)-3-(propanoyloxy)-4-(trimethylazaniumyl)butanoate
- Mol formula
- C10H19NO4
- Mol weight
- 217 Da
- Catalog Number(s)
- AA007VK9, AD241005, AD67397, AG007VN1, AG00C1Q6, AR007WC1, AS-86158, BBV-77794585, BD00879062, CS-0083093, CSC054050353, FCH3561365, FP36310, G76857, HY-121705, J10133, JH174941, LN04732743, P227190, T1182L, Y1265701
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -3.75
- Heavy atoms count
- 15
- Rotatable bond count
- 7
- Number of rings
- 0
- Carbon bond saturation, Fsp3
- 0.8
- Polar surface area (Å)
- 66
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSS00054050353
Items Overall 9 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 95 | 5 mg | 80 | |
MedChemExpress | 10 days | United States To: | 95 | 10 mg | 120 | |
Description: Names: Propionyl-L-carnitine; Product Description: Propionyl-L-carnitine is a carnitine derivative and has a high affinity for muscular carnitine transferase . Propionyl-L-carnitine increases cellular carnitine content, thereby allowing free fatty acid transport into the mitochondria. Propionyl-L-carnitine alleviates the symptoms of PAD through a metabolic pathway, thereby improving exercise performance .; Target: Endogenous Metabolite; CAS: 20064-19-1 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 95 | 5 mg | 85 | |
MedChemExpress EU | 10 days | Sweden To: | 95 | 10 mg | 126 | |
Description: Names: Propionyl-L-carnitine; Product Description: Propionyl-L-carnitine is an orally active L-carnitine derivative. Propionyl-L-carnitine has a high affinity for muscle L-carnitine transferase. Propionyl-L-carnitine increases Apoptosis, Bax, and reduces NF-κB, VCAM-1, MCP-1, and survivin. Propionyl-L-carnitine activates Src kinase, Akt, induces p-AMPK and nitric oxide synthesis. Propionyl-L-carnitine alleviates cardiovascular disease, obesity, and colitis; Target: Akt;AMPK;Apoptosis;Bcl-2 Family;Endogenous Metabolite;NF-κB;NO Synthase;Src;Survivin; CAS: 20064-19-1 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 1 mg | 45 | |
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 5 mg | 98 | |
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 10 mg | 152 | |
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 25 mg | 258 | |
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 50 mg | 387 | |
Description: Levocarnitine propionate (L-Propionylcarnitine) is a propionyl-coenzyme A (Pro-CoA) derivative with anti-ischemic effects and high affinity for muscle L-carnitine transferase. Levocarnitine propionate enhances substrate oxidation and mitochondrial respiration in the heart of diabetic rats, reduces gastric ulcer area, induces mucosal recovery, and can be used to study acute respiratory distress syndrome and chronic gastric ulcers in Alzheimer's disease.; CAS: 20064-19-1 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire